AbbVie Inks Deal To Develop, Sell I-Mab’s Cancer Therapy
Weekly Market Review: Rally Pauses Ahead of Holiday
Vertex and Covid-19 spell the end for Savara's CF program
Steroids cut COVID-19 death rates, but not for everyone – here’s who benefits and who doesn’t
One Bank Warns The Coming Flu Season Could Lead To Chaos
Researchers identify nanobody that may prevent COVID-19 infection
Is Trevena Stock a Buy Right Now? This Is What You Need to Know
Compass plans $100m IPO to fund magic mushroom depression drug
How to spot patients most likely to die from blood infections
CRISPR can help combat the troubling immune response against gene therapy
How to Stymie Distribution of a Potentially Dangerous Vaccine
Trial to test nasal irrigations as COVID-19 treatment
Addiction treatment shrinks during the pandemic, leaving people with nowhere to turn
A sea-change for pharma? Pandemic commercial models and launch
S&P Futures Inexplicably Dip As "Magical, Non-Stop Rally" Reverses
As Covid research heats up, J&J retires a BARDA-funded flu antiviral they worked on for 7 years
Sanofi, GSK launch trial for Covid-19 protein-based vaccine
EU regulators begin fast review of dexamethasone for COVID-19
Plasmin could be the link between COVID-19 comorbidities and serious illness
Vanderbilt launches clinical trial of outpatient treatments for COVID-19
United Airlines To Slash 16,370 Jobs As Air Travel Sinks
J&J Abandons Influenza A Treatment Program After Interim Analysis
Steroids cut death rates among critically ill Covid-19 patients, major study finds
What happens to the plastic you recycle? Researchers lift the lid
'Science Deniers'? - Delaying Herd Immunity Is Costing Lives
A ‘Human’ Touch vs. COVID-19
GSK and Vir take COVID-19 antibody therapy into clinic
Bristol Myers Scores FDA Nod For Acute Myeloid Leukemia Treatment
Oppenheimer: These 3 Penny Stocks Have Triple-Digit Upside Potential
NIH Attacks FDA Over 'Premature' Approval Of 'Trump-Backed' Convalescent Plasma